Takeda Pharmaceutical Co Ltd, et al v. Zydus Pharmaceuticals (USA) In, et al
TAKEDA PHARMACEUTICAL CO LTD, TAKEDA PHARMACEUTICALS USA INC and TAKEDA PHARMACEUTICALS AMERICA INC |
ZYDUS PHARMACEUTICALS (USA) INC and CADILA HEALTHCARE LTD |
21-2608 |
August 30, 2021 |
U.S. Court of Appeals, Third Circuit |
Other |
Opinions
We have the following opinions for this case:
Description |
---|
Takeda Pharmaceutical Co Ltd v. Zydus Pharmaceuticals (USA) In |
Docket Report
This docket was last retrieved on August 30, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 3 ORDER (Clerk) Appellants filed a notice of appeal to this Court from the District Court's August 17, 2021, final judgment, and every decision proceeding the judgment. It appears that the underlying case asserts claims of patent infringement under 35 U.S.C. Section 271. Exclusive jurisdiction for cases arising under patent laws, however, rests with the United States Court of Appeals for the Federal Circuit. See 28 U.S.C. Sections 1295, 1338. The parties are hereby ORDERED to show cause within fourteen (14) days of the date of this order why the appeal should not be transferred to the United States Court of Appeals for the Federal Circuit. (TMM) [Entered: 08/30/2021 11:30 AM] |
Filing 2 RECORD available on District Court CM/ECF. (TMM) [Entered: 08/30/2021 11:21 AM] |
Filing 1 CIVIL CASE DOCKETED. Notice filed by Appellants Cadila Healthcare Ltd and Zydus Pharmaceuticals (USA) Inc in District Court No. 3-18-cv-01994. (TMM) [Entered: 08/30/2021 11:18 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.